Lisdexamfetamine, marketed as Vyvanse, is a prescription medication approved for attention deficit hyperactivity disorder in kids and adults . In Canada, its distribution is overseen by Health Canada. This https://apo-lisdexamfetamine-for818713.thezenweb.com/this-medication-in-canada-a-detailed-guide-82023339